- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02136459
Non-neural Vocal Changes After Thyroidectomy
Assessment of Non-neural Voice Changes in Thyroidectomy Patients: A Randomized Control Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The optimum size of endotracheal tube (ETT) for general anaesthesia remains a matter of debate. Choice of ETT size may be of particular pertinence during thyroid surgery, for a number or reasons. Because of the strong attachments of the thyroid gland to the trachea, intraoperative mobilization of the thyroid will lead to inevitable movement of the trachea and larynx against the fixed ETT, with consequent risk of traumatic injury to tracheal mucosa, vocal cords, and arytenoids. Thus thyroidectomy is likely to be associated with a greater risk of laryngeal trauma related to the ETT than operations outside the Head and Neck region where there is no movement of the larynx. On top of this, postoperative vocal impairment comprises one of the most important concerns after thyroidectomy, usually attributed to impaired vocal fold function secondary to recurrent laryngeal nerve injury. However, post-thyroidectomy vocal impairment can also occur in cases where the recurrent laryngeal nerve is preserved. Thus, concerns regarding vocal outcomes after thyroidectomy tend to be foremost in the mind of both the surgeon and the patient, and any measures which can be taken to minimize post-thyroidectomy hoarseness, which might include choosing the optimal ETT size, would appear to constitute a worthwhile endeavor.
Laryngeal trauma due to endotracheal intubation is probably more common than appreciated, however, given that symptoms of sore throat and hoarseness after most operations are generally self-limiting, this is not usually a major cause of concern. On the other hand, postoperative vocal symptoms may be a major cause of anxiety after thyroidectomy, due to fear of damage to the recurrent laryngeal nerve or the external branch of the superior laryngeal nerve (SLN). Laryngeal trauma without impairment of vocal fold function has been reported to be a significant cause of vocal symptoms after thyroid surgery. However, no previously published study has attempted to correlate post-thyroidectomy vocal symptoms or signs of laryngeal trauma with ETT size.
The hypothesis of the present study was that intubation with a smaller size ETT would lead to less trauma to the larynx during thyroidectomy than intubation with a standard size tube, and this would be reflected through less postoperative throat symptoms and objective laryngeal alterations. The rationale for this hypothesis was that a smaller caliber tube would be less unyielding when the larynx is moved against it, and thus would lead to less laryngeal injury. In order to address this question, the investigators designed a randomized controlled trial, comparing the impact of intubation with a smaller size tube (size 6.5 for females, and size 7 for males) with that of intubation with ETTs of the standard size used in the investigators department (size 7.5 for females, and size 8 for males).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cork, Ireland
- South Infirmary Victoria University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients aged 18 years and over scheduled to undergo thyroid surgery performed by one of two surgeons for benign or malignant thyroid disease during the study
Exclusion Criteria:
- pre-existing vocal cord palsy or major vocal cord pathology; patients with invasive thyroid cancers; and patients undergoing concomitant lateral neck dissection
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Small tube size
Size 6.5 ETT for female, size 7.0 ETT for male
|
An endotracheal tube of size 6.5 in females and 7.0 in males was used for endotracheal intubation of patients undergoing thyroid surgery
Other Names:
|
Active Comparator: Large tube size
Normal tube size, size 7.5 for female, size 8 for male
|
An endotracheal tube of size 7.5 in females and 8.0 in males was used for endotracheal intubation of patients undergoing thyroid surgery
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Laryngoscopic appearance
Time Frame: 24 hours
|
A laryngoscopic score of 0,1,2 was given according to absence (0), presence (1) or presence of severe (2) findings of each the following laryngoscopic findings: erythema, oedema, polyp or nodule, and reduced vocal mobility
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vocal outcomes
Time Frame: 24 hours
|
Grade, roughness, breathiness, aesthenia and strain (GRBAS) score
|
24 hours
|
Laryngoscopic appearance
Time Frame: 3 weeks
|
A laryngoscopic score of 0,1,2 was given according to absence (0), presence (1) or presence of severe (2) findings of each the following laryngoscopic findings: erythema, oedema, polyp or nodule, and reduced vocal mobility
|
3 weeks
|
Objective vocal outcomes
Time Frame: 3 weeks
|
Grade, roughness, breathiness, aesthenia and strain (GRBAS) score
|
3 weeks
|
Subjective vocal outcomes
Time Frame: 3 weeks
|
VHI (Voice Handicap Index) scores
|
3 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain
Time Frame: 24 hours
|
VAS score
|
24 hours
|
Collaborators and Investigators
Investigators
- Principal Investigator: Rania Mehanna, South Infirmary-Victoria University Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- SIVUH1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thyroidectomy
-
Kyungpook National University Chilgok HospitalRecruitingThyroidectomyKorea, Republic of
-
Aristotle University Of ThessalonikiCompleted
-
Keimyung University Dongsan Medical CenterUnknown
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
NYU Langone HealthCompleted
-
Yonsei UniversityCompletedThyroidectomyKorea, Republic of
-
Yonsei UniversityCompleted
-
Genexine, Inc.SymyooCompletedTotal Thyroidectomy | Near-total ThyroidectomyKorea, Republic of
-
Seoul National University HospitalCompletedRobotic ThyroidectomyKorea, Republic of
-
Antalya Training and Research HospitalCompleted
Clinical Trials on Small Tube size
-
Amsterdam UMC, location VUmcCompletedOccupational Injuries | ClothingNetherlands
-
Vendsyssel HospitalCompletedHoarseness | Sore ThroatDenmark
-
University of LiverpoolCompletedEating Behavior
-
The First Affiliated Hospital of Soochow UniversityCompleted
-
Penn State UniversityJenny Craig, Inc.Withdrawn
-
The University of Texas Health Science Center,...Recruiting
-
Mansoura UniversityUnknownPain | Urolithiasis | Nephrolithotomy | Percutaneous Nephrolithotomy (PNL) | Nephrostomy Tube (NT)Egypt
-
University of ManitobaSaskatchewan Pulse Growers; Alberta Pulse GrowersCompleted
-
Region StockholmCompleted
-
University of ManitobaSaskatchewan Pulse Growers; Alberta Pulse GrowersCompleted